Leukemia Protein Atlas Holds Power to Accelerate Precision Medicine

Statistics can be a great tool for analyzing datasets and it can also be a sobering means to provide a stark reality. For instance,...

Thermo Fisher, NX Prenatal to Develop NIPT Proteomics Assays

Thermo Fisher Scientific will combine its liquid chromatography-mass spectrometry (LC-MS) instrumentation with NX Prenatal’s NeXosome platform to develop proteomics assays designed to offer noninvasive...

Genomenon, Parabricks Offer Products Via Google Cloud Platform

A pair of companies specializing in applying computing to genomics said today they will make their products available via Google Cloud Platform, through partnerships...

Stanford Studies Feasibility of AI Platform for Blood Cancer Precision Treatments

The AI platform from Notable completed personalized treatment recommendations for all 20 patients within 30 days demonstrating both a positive and negative predictive value average of 84 percent.
DNA mutation with green wrench twisting a red nut

Algorithm IDs Cancer Patients for Precision Treatments by Decoding Mutational Signatures

A new algorithm analyzes patterns in mutational profiles to identify cancer patients with underlying defects in DNA repair machinery, guiding targeted therapies.

DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study

Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis DNAnexus, UPMC, and Sutter Health network said today they have launched a...
Colon cancer. Cancer attacking cell. Colon disease concept

CRC Evades Immunotherapies by Regulating Expression of Cell Surface Molecule

CRC tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy, thus preventing the treatment from working.

Sophia Genetics Gains CE-IVD Marking for Solid Tumor Solution

Sophia Genetics has obtained the CE-IVD marking for its Solid Tumor Solution (STS), a molecular diagnostic application designed to precisely detect and characterize all...

Evotec, Individumed Partner on Precision Medicine for Colorectal Cancer

Evotec and Individumed said today they will partner to develop new precision therapeutics for colorectal cancer (CRC), through a collaboration whose value was not...
Prostate cancer cells, illustration

Helomics, SpeciCare Enter Live Tumor Tissue Precision Cancer Care Collaboration

Helomics will provide CRO services and its D-CHIP artificial intelligence (AI) platform for a functional precision medicine study called PIONEER sponsored by SpeciCare.
Scroll Up